关注
Fassett R
Fassett R
Professor, Human Movement Studies, The University of Queensland
在 uq.edu.au 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Biomarkers in chronic kidney disease: a review
RG Fassett, SK Venuthurupalli, GC Gobe, JS Coombes, MA Cooper, ...
Kidney international 80 (8), 806-821, 2011
5812011
Astaxanthin: a potential therapeutic agent in cardiovascular disease
RG Fassett, JS Coombes
Marine drugs 9 (3), 447-465, 2011
4232011
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
B Bose, SV Badve, SS Hiremath, N Boudville, FG Brown, A Cass, ...
Nephrology Dialysis Transplantation 29 (2), 406-413, 2014
2592014
Effect of intradialytic versus home-based aerobic exercise training on physical function and vascular parameters in hemodialysis patients: a randomized pilot study
KP Koh, RG Fassett, JE Sharman, JS Coombes, AD Williams
American Journal of Kidney Diseases 55 (1), 88-99, 2010
2532010
Detection of glomerular bleeding by phase-contrast microscopy
RG Fassett, BA Horgan, TH Mathew
The Lancet 319 (8287), 1432-1434, 1982
2501982
Sulforaphane and other nutrigenomic Nrf2 activators: can the clinician’s expectation be matched by the reality?
CA Houghton, RG Fassett, JS Coombes
Oxidative medicine and cellular longevity 2016 (1), 7857186, 2016
2472016
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and …
PL Drury, R Ting, D Zannino, C Ehnholm, J Flack, M Whiting, R Fassett, ...
Diabetologia 54, 32-43, 2011
2262011
Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease
A Crawford, RG Fassett, DP Geraghty, DA Kunde, MJ Ball, IK Robertson, ...
Gene 501 (2), 89-103, 2012
2252012
Astaxanthin in cardiovascular health and disease
RG Fassett, JS Coombes
Molecules 17 (2), 2030-2048, 2012
2232012
Astaxanthin, oxidative stress, inflammation and cardiovascular disease
RG Fassett, JS Coombes
Future cardiology 5 (4), 333-342, 2009
2052009
Oxidative stress biomarkers as predictors of cardiovascular disease
NA Strobel, RG Fassett, SA Marsh, JS Coombes
International journal of cardiology 147 (2), 191-201, 2011
1862011
Exercise & Sports Science Australia (ESSA) position statement on exercise and chronic kidney disease
NA Smart, AD Williams, I Levinger, S Selig, E Howden, JS Coombes, ...
Journal of Science and Medicine in Sport 16 (5), 406-411, 2013
1832013
Sulforaphane: translational research from laboratory bench to clinic
CA Houghton, RG Fassett, JS Coombes
Nutrition reviews 71 (11), 709-726, 2013
1802013
Antioxidant therapy in hemodialysis patients: a systematic review
JS Coombes, RG Fassett
Kidney international 81 (3), 233-246, 2012
1772012
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection
AC Bulmer, JT Blanchfield, I Toth, RG Fassett, JS Coombes
Atherosclerosis 199 (2), 390-396, 2008
1722008
A novel hypoxia-inducible factor− prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2A randomized trial
RA Brigandi, B Johnson, C Oei, M Westerman, G Olbina, J De Zoysa, ...
American Journal of Kidney Diseases 67 (6), 861-871, 2016
1702016
Taming the chronic kidney disease epidemic: a global view of surveillance efforts
J Radhakrishnan, G Remuzzi, R Saran, DE Williams, N Rios-Burrows, ...
Kidney international 86 (2), 246-250, 2014
1682014
Guidelines for glycerol use in hyperhydration and rehydration associated with exercise
SP van Rosendal, MA Osborne, RG Fassett, JS Coombes
Sports Medicine 40, 113-139, 2010
1522010
Palliative care in end‐stage kidney disease
RG Fassett, IK Robertson, R Mace, L Youl, S Challenor, R Bull
Nephrology 16 (1), 4-12, 2011
1402011
A Multi-Center Comparison of O2peak Trainability Between Interval Training and Moderate Intensity Continuous Training
CJ Williams, BJ Gurd, JT Bonafiglia, S Voisin, Z Li, N Harvey, I Croci, ...
Frontiers in physiology 10, 19, 2019
1182019
系统目前无法执行此操作,请稍后再试。
文章 1–20